GB1161414A - Vaccines against Measles and process for their manufacture - Google Patents

Vaccines against Measles and process for their manufacture

Info

Publication number
GB1161414A
GB1161414A GB38126/66A GB3812666A GB1161414A GB 1161414 A GB1161414 A GB 1161414A GB 38126/66 A GB38126/66 A GB 38126/66A GB 3812666 A GB3812666 A GB 3812666A GB 1161414 A GB1161414 A GB 1161414A
Authority
GB
United Kingdom
Prior art keywords
vaccine
measles
virus
vaccines
aug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38126/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1161414A publication Critical patent/GB1161414A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB38126/66A 1965-08-28 1966-08-25 Vaccines against Measles and process for their manufacture Expired GB1161414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB83486A DE1247548B (de) 1965-08-28 1965-08-28 Verfahren zur Herstellung einer Masern-Vaccine

Publications (1)

Publication Number Publication Date
GB1161414A true GB1161414A (en) 1969-08-13

Family

ID=6981993

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38126/66A Expired GB1161414A (en) 1965-08-28 1966-08-25 Vaccines against Measles and process for their manufacture

Country Status (9)

Country Link
AT (1) AT281280B (enExample)
BE (1) BE686101A (enExample)
BR (1) BR6682416D0 (enExample)
CH (1) CH484277A (enExample)
DE (1) DE1247548B (enExample)
DK (2) DK119938B (enExample)
FR (2) FR1502631A (enExample)
GB (1) GB1161414A (enExample)
NL (1) NL6611851A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446A (zh) * 2014-12-15 2015-04-08 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446A (zh) * 2014-12-15 2015-04-08 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法
CN104498446B (zh) * 2014-12-15 2017-03-15 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法

Also Published As

Publication number Publication date
DE1247548B (de) 1967-08-17
AT281280B (de) 1970-05-11
DK119938B (da) 1971-03-15
BR6682416D0 (pt) 1973-12-04
CH484277A (de) 1970-01-15
FR1502631A (fr) 1967-11-24
BE686101A (enExample) 1967-02-28
FR5666M (enExample) 1968-01-02
NL6611851A (enExample) 1967-03-01
DK121811B (da) 1971-12-06

Similar Documents

Publication Publication Date Title
Zinsser et al. A study of rickettsiae grown on agar tissue cultures
Magill et al. Studies with human influenza virus cultivated in artificial medium
ES336810A1 (es) Un metodo para producir una cepa de celulas.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1161414A (en) Vaccines against Measles and process for their manufacture
Morgan et al. Latent viral infection of cells in tissue culture: IV. Latent infection of L cells with psittacosis virus
GB1604003A (en) Process for the cultivation of viruses
US4021302A (en) Cell cultures
US3567585A (en) Process for obtaining bcg-cultures
Loebenstein Native protein, an immunizing agent against virus infection
Sellers et al. The behaviour of strains of the virus of foot-and-mouth disease in pig, calf, ox and lamb kidney tissue cultures
US4112068A (en) Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom
DE2041647A1 (de) Zellreihe aus der Leber menschlicher Embryonen,Verfahren zu deren Herstellung und deren Verwendung
GB1274820A (en) Highly attenuated newcastle disease virus vaccine and production thereof
SATO et al. Cellular Basis of Immunity. II Inhibition of the Intracellular Multiplication of Salmonella enteritidis in Mouse Phagocytes of the Liver and Subscutaneous Tissue Immunized with Live Vaccine
Churchill Intranuclear inclusions produced by bovine para-influenza
Matumoto et al. Behavior of bovine ephemeral fever virus in laboratory animals and cell cultures
GB1133958A (en) Process for the manufacture of a distemper vaccine
Franklin et al. CULTIVATION OF POLIOMYELITIS VIRUS IN TISSUE CULTURE IV. FURTHER OBSERVATIONS ON VIRUS PROPAGATION IN HUMAN TISSUES WITH A SYNTHETIC NUTRIENT MEDIUM
US3725542A (en) Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it
US3843451A (en) Microorganism production
Rockwell et al. Carbon dioxide as a factor in the growth of the tubercle bacillus and of other acidfast organisms
Siegel In Vitro Cultivation of Mouse Ascites Tumour Cells for Virus–Host Cell Studies
Hotta Some immunological properties of dengue virus cultivated in tissue culture
GB1070764A (en) Improvements in or relating to a process for culturing tissue cells

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee